Evidence map›Paper›PMID 42598092›Full record

ArticleIranian journal of parasitology

Green Synthesized Gold Nanoparticles Ameliorate the

Leila Masoori, Ruaa Majid Khazaal, Marzieh Rashidipour, Maryam Sepahvand, Hossein Mahmoudvand

Abstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leila MasooriRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Ruaa Majid KhazaalDepartment of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah, Iraq.
Marzieh RashidipourRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Maryam SepahvandStudent Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Hossein MahmoudvandHepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In immunocompromised individuals, Methods: Mice were immunosuppressed using dexamethasone prior to infection with the Tehran strain of Results: Synthesized AuNPs exhibited cubic morphology with an average size of 20-30 nm. Combined AuNPs-PYR treatment significantly improved survival and reduced brain cyst burden ( Conclusion: AuNPs, particularly in combination with PYR, demonstrate significant efficacy against toxoplasmosis in immunosuppressed murine models. Clinical trials are warranted to further assess the safety and therapeutic potential of this combination approach.

Indexed as

BradyzoitesImmunosuppressionNanomedicineToxoplasmosis

Identifiers

PMID42598092
PMCPMC13471231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.